AU Patent

AU2003255355A1 — Progesterone receptor modulators having an increased antigonadotropic activity for use in female fertility testing and hormone replacement therapy

Assigned to Bayer Pharma AG · Expires 2004-02-25 · 22y expired

What this patent protects

The invention relates to novel compounds of general formula (I), to the production thereof and to pharmaceutical preparations containing these compounds. The inventive compounds are preferably used in female fertility testing and hormone replacement therapy.

USPTO Abstract

The invention relates to novel compounds of general formula (I), to the production thereof and to pharmaceutical preparations containing these compounds. The inventive compounds are preferably used in female fertility testing and hormone replacement therapy.

Drugs covered by this patent

Patent Metadata

Patent number
AU2003255355A1
Jurisdiction
AU
Classification
—
Expires
2004-02-25
Drug substance claim
No
Drug product claim
No
Assignee
Bayer Pharma AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.